查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433539

gRNA 市場規模、佔有率、趨勢分析報告：按產品/服務、按 gRNA 類型、按應用、按最終用途、按地區、細分市場預測，2024-2030 年

gRNA Market Size, Share & Trends Analysis Report By Product & Services (Products, Custom gRNA Synthesis Services), By gRNA Type (Research-Use), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

gRNA 市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球gRNA市場規模預計將達到16.2億美元，預計2024年至2030年複合年成長率為18.6%。

次世代定序(NGS) 的日益普及正在顯著推動市場發展。隨著NGS技術變得普及，它將為研究人員和科學家提供先進的基因組分析和操作能力。 NGS 能夠對遺傳物質進行高通量定序，從而能夠快速且經濟高效地查詢整個基因組。這種效率對於 gRNA 應用至關重要，因為它有助於識別和檢驗用於遺傳操作的目標基因。 NGS 技術提供了對基因組序列的準確和全面的了解。這種精確度對於設計高特異性 gRNA 至關重要，以確保在使用 CRISPR/Cas 系統的基因編輯過程中精確地標靶基因。

此外，生技和製藥公司增加對研發活動的投資預計將在未來幾年提振市場。使用者友好且負擔得起的 gRNA 合成套件和服務的開發使各級研究人員更容易使用 CRISPR-Cas9 技術。 CRISPR-Cas9 新應用的持續發現推動了對 gRNA 的需求。

此外，新gRNA最終產品的推出可以促進技術創新，擴大參與者的市場範圍，加速基因編輯技術的採用，並為整體市場的成長和進步做出貢獻。例如，2023 年 10 月，著名的基因組工程解決方案提供者 Synthego 推出了 IND 支援 (INDe) gRNA。這項創新產品代表了基於 CRISPR 的細胞和基因療法前臨床開發平臺的重大進步。該產品在整個設計和製造過程中結合了全面的 IND 合規材料和材料，為研究人員提供精心設計的高品質 gRNA，用於 GLP 監管的臨床前和 IND 支持的研究。包括文件。因此，它成為市場成長的驅動力。

gRNA 市場報告亮點

  • 按產品和服務分類，產品部門佔收益佔有率最大，2023年為73.4%。這些產品在基因編輯方面具有高精度、高效率和特異性，使其受到研究人員的歡迎，也是推動市場擴張的主要因素。
  • 按 gRNA 類型分類，研究領域在 2023 年佔據了市場佔有率。各研究機構正在進行的眾多研究計畫都需要研究級 gRNA，從而推動了這一領域的需求。
  • 從應用來看，基因組工程領域在2023年佔據市場佔有率。這種成長是由於對用於研究和治療目的的先進遺傳工具的需求不斷增加。
  • 按最終用途分類，製藥和生物技術公司在 2023 年佔據市場佔有率。製藥和生物技術公司在精準醫療中採用 gRNA 將推動市場成長，因為它對於開發個人化治療至關重要。
  • 由於該地區主要市場參與者的存在，北美在 2023 年以 52.6% 的銷售佔有率在全球行業中佔據主導地位。

目錄

第1章調查方法與範圍

第 2 章 gRNA 市場：執行摘要

  • 市場展望
  • 分段簡介
  • 競爭形勢概覽

第 3 章 gRNA 市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 次世代定序的採用率增加
    • 蛋白質體學和基因組學研究和開發的成長
    • 個人化醫療的採用增加
  • 市場限制因素分析
    • 監管挑戰
    • 脫靶效應與安全問題
  • 營商環境分析
    • 波特五力分析
    • PESTLE分析
  • COVID-19 分析

第4章 產品和服務的估算和趨勢分析

  • gRNA市場：產品和服務的波動分析
  • 產品
    • 2018-2030 年產品市場估計與預測
    • gRNA最終產品
    • gRNA合成產品
  • 自訂gRNA合成服務
    • 2018-2030 年自訂gRNA 合成服務市場估計與預測

第5章 gRNA類型估計及趨勢分析

  • gRNA市場：gRNA類型波動分析
  • 研究用途
  • GMP級

第 6 章 使用估算/趨勢分析

  • gRNA市場：應用變異分析
  • 基因組工程
    • 2018-2030 年基因組工程市場收益估計與預測
  • 疾病模型研究
    • 2018-2030年疾病建模研究市場收益估算與預測
  • 功能基因體學
    • 2018-2030 年功能基因體學市場收益估計與預測
  • 磊晶
    • 磊晶市場收益估算與預測，2018-2030
  • 其他
    • 2018-2030 年其他市場收益估計與預測

第7章 最終用途估算及趨勢分析

  • gRNA 市場：最終用途變異分析
  • 製藥和生物技術公司
  • 學術研究所
  • 首席行銷長和首席研究官

第8章區域業務分析

  • 區域市場簡介
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 公司分類
  • 策略規劃
    • 獲得
    • 產品/服務發布
    • 夥伴關係/協作
    • 其他
  • 2023 年市場分析
  • 公司簡介
    • Thermo Fisher Scientififc, Inc
    • Agilent Technologies, Inc.
    • System Biosciences, LLC.
    • Jena Bioscience GmbH
    • Merck KGaA
    • Azenta Life Sciences（Genewiz）
    • Takara Bio Inc.
    • Synbio Technologies
    • Revvity Inc（Horizon Discovery Ltd.）
    • Synthego
Product Code: GVR-4-68040-180-5

gRNA Market Growth & Trends:

The global gRNA market size is anticipated to reach USD 1.62 billion by 2030 and it is projected to grow at a CAGR of 18.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising adoption of Next-Generation Sequencing (NGS) is significantly boosting the market. As NGS technologies become more prevalent, they empower researchers and scientists with advanced capabilities for genomic analysis and manipulation. NGS enables high-throughput sequencing of genetic material, allowing for the rapid and cost-effective examination of entire genomes. This efficiency is crucial for gRNA applications, as it facilitates the identification and validation of target genes for genetic manipulation. NGS technologies provide a precise and comprehensive understanding of genomic sequences. This precision is vital for designing gRNAs with high specificity, ensuring accurate targeting of genes during the gene editing process using CRISPR/Cas systems.

Furthermore, the increasing investments by biotechnology and pharmaceutical companies for R&D activities are expected to fuel the market in the coming years. The development of user-friendly and affordable gRNA synthesis kits and services has made CRISPR-Cas9 technology more accessible to researchers of all levels. The continuous discovery of novel applications for CRISPR-Cas9 fuels the demand for gRNA.

Additionally, the launch of new gRNA final products can drive innovation, expand the market reach of players, and accelerate the adoption of gene editing technologies, contributing to the overall growth & advancement of the market. For instance, in October 2023, Synthego, a prominent provider of genome engineering solutions, launched IND-enabling (INDe) gRNAs. This transformative offering marks a significant advancement in the CRISPR-based cell and gene therapy preclinical pipeline. By providing researchers with high-quality gRNAs meticulously designed for GLP-regulated preclinical and IND-enabling studies, this product incorporates comprehensive IND-compliant materials and documentation throughout its design and production. Thus, it will drive the market growth.

gRNA Market Report Highlights:

  • On the basis of product & services, the product segment accounted for the largest revenue share of 73.4% in 2023. These products offer high accuracy, efficiency, and specificity in gene editing, making them popular among researchers is one of the primary drivers driving market expansion
  • On the basis of gRNA type, the research-use segment dominated the market share in 2023. A large number of research programs conducted across various research institutes demand research-grade gRNA is driving up demand for this segment
  • On the basis of application, the genome engineering segment dominated the market share in 2023. This growth can be attributed to the increasing demand for advanced genetic tools for research and therapeutic purposes
  • On the basis of end-use, the pharmaceutical & biotechnology companies segment dominated the market share in 2023. The adoption of gRNA in precision medicine by pharmaceutical and biotech companies fuels its market growth as it becomes integral to the development of personalized therapies
  • North America dominated the global industry in 2023 with a revenue share of 52.6% owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Information Analysis
  • 1.3. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. gRNA Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. gRNA Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Increase in adoption of Next-Generation Sequencing
    • 3.4.2. Growing R&D in proteomics and genomics
    • 3.4.3. Increasing adoption of personalized medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory Challenges
    • 3.5.2. Off-Target Effects and Safety Concerns
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis
  • 3.7. COVID-19 Analysis

Chapter 4. Product & Services Estimates & Trend Analysis

  • 4.1. gRNA market: Product & Services Movement Analysis
  • 4.2. Products
    • 4.2.1. Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. gRNA Final Products
      • 4.2.2.1. gRNA Final Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. gRNA Synthesis Products
      • 4.2.3.1. gRNA Synthesis Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.2. gRNA Synthesis Kits
      • 4.2.3.2.1. gRNA Synthesis Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.3. Plasmids
      • 4.2.3.3.1. Plasmids Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.2.3.4. Others
      • 4.2.3.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Custom gRNA Synthesis Services
    • 4.3.1. Custom gRNA Synthesis Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. gRNA Type Estimates & Trend Analysis

  • 5.1. gRNA market: gRNA Type Movement Analysis
  • 5.2. Research-Use
    • 5.2.1. Research-Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. GMP-grade
    • 5.3.1. GMP-grade Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Application Estimates & Trend Analysis

  • 6.1. gRNA market: Application Movement Analysis
  • 6.2. Genome Engineering
    • 6.2.1. Genome Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Disease Model Studies
    • 6.3.1. Disease Model Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Functional Genomics
    • 6.4.1. Functional Genomics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Epigenetics
    • 6.5.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. End-Use Estimates & Trend Analysis

  • 7.1. gRNA market: End-Use Movement Analysis
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Academic Research Institutes
    • 7.3.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. CMOs & CROs
    • 7.4.1. CMOs & CROs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America gRNA Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. U.S. gRNA Market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Canada gRNA Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. UK gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. Germany gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.4. Spain
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. Spain gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. France gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. Italy gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Denmark gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Target Disease Prevalence
      • 8.3.8.5. Sweden gRNA Market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Target Disease Prevalence
      • 8.3.9.5. Norway gRNA Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Japan gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. China gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. India gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Target Disease Prevalence
      • 8.4.5.5. South Korea gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Target Disease Prevalence
      • 8.4.6.5. Thailand gRNA Market, 2018 - 2030 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Target Disease Prevalence
      • 8.4.7.5. Australia gRNA Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America gRNA Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. Brazil gRNA Market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Mexico gRNA Market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Argentina gRNA Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Target Disease Prevalence
      • 8.6.2.5. South Africa gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. Saudi Arabia gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. UAE gRNA Market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. Kuwait gRNA Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Product/service launch
    • 9.2.3. Partnerships/Collaborations
    • 9.2.4. Others
  • 9.3. Market Position Analysis, 2023
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientififc, Inc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Agilent Technologies, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. System Biosciences, LLC.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Jena Bioscience GmbH
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Merck KGaA
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Azenta Life Sciences (Genewiz)
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Benchmarking
      • 9.4.6.3. Strategic Initiatives
    • 9.4.7. Takara Bio Inc.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Synbio Technologies
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Revvity Inc (Horizon Discovery Ltd.)
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Synthego
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 4 Global gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 5 Global gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 6 Global gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 7 Global gRNA market, by Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 10 North America gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 11 North America gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 12 North America gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 15 U.S. gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 16 U.S. gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 17 Canada gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 18 Canada gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 19 Canada gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 20 Canada gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 21 Europe gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 22 Europe gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 23 Europe gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 24 Europe gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 25 Europe gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 26 UK gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 27 UK gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 28 UK gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 29 UK gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 30 Germany gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 31 Germany gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 32 Germany gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 33 Germany gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 34 France gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 35 France gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 36 France gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 37 France gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 38 Italy gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 39 Italy gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 40 Italy gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 41 Italy gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 42 Spain gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 43 Spain gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 44 Spain gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 45 Spain gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Sweden gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 47 Sweden gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 48 Sweden gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 49 Sweden gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 50 Norway gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 51 Norway gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 52 Norway gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 53 Norway gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 54 Denmark gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 55 Denmark gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 56 Denmark gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 57 Denmark gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 58 Asia Pacific gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 59 Asia Pacific gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 60 Asia Pacific gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 61 Asia Pacific gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 62 Asia Pacific gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 63 Japan gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 64 Japan gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 65 Japan gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 66 Japan gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 67 China gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 68 China gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 69 China gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 70 China gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 71 India gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 72 India gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 73 India gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 74 India gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 75 Australia gRNA arket, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 76 Australia gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 77 Australia gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 78 Australia gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 79 South Korea gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 80 South Korea gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 81 South Korea gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 82 South Korea gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 83 Thailand gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 84 Thailand gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 85 Thailand gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 86 Thailand gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 87 Latin America gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 88 Latin America gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 89 Latin America gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 90 Latin America gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 91 Latin America gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 92 Brazil gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 93 Brazil gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 94 Brazil gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 95 Brazil gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 96 Mexico gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 97 Mexico gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 98 Mexico gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 99 Mexico gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 100 Argentina gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 101 Argentina gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 102 Argentina gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 103 Argentina gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 104 MEA gRNA market, by Country, 2018 - 2030 (USD Million)
  • TABLE 105 MEA gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 106 MEA gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 107 MEA gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 108 MEA gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 109 South Africa gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 110 South Africa gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 111 South Africa gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 112 South Africa gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 113 Saudi Arabia gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 114 Saudi Arabia gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 115 Saudi Arabia gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 116 Saudi Arabia gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 117 UAE gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 118 UAE gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 119 UAE gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 120 UAE gRNA market, by End-Use, 2018 - 2030 (USD Million)
  • TABLE 121 Kuwait gRNA market, by Product & Services, 2018 - 2030 (USD Million)
  • TABLE 122 Kuwait gRNA market, by gRNA Type, 2018 - 2030 (USD Million)
  • TABLE 123 Kuwait gRNA market, by Application, 2018 - 2030 (USD Million)
  • TABLE 124 Kuwait gRNA market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market Research Process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 gRNA market Segmentation
  • FIG. 8 Market Snapshot, 2023
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Market Penetration & Growth Prospect Mapping, 2023
  • FIG. 15 Global gRNA market: Product & Services Movement Analysis
  • FIG. 16 Global gRNA market, For Products, 2018 - 2030 (USD Million)
  • FIG. 17 Global gRNA market, For gRNA Final Products, 2018 - 2030 (USD Million)
  • FIG. 18 Global gRNA market, For gRNA Synthesis Products, 2018 - 2030 (USD Million)
  • FIG. 19 Global gRNA market, For gRNA Synthesis Kits, 2018 - 2030 (USD Million)
  • FIG. 20 Global gRNA market, For Plasmids, 2018 - 2030 (USD Million)
  • FIG. 21 Global gRNA market, For Others, 2018 - 2030 (USD Million)
  • FIG. 22 Global gRNA market, For Custom gRNA Synthesis Services, 2018 - 2030 (USD Million)
  • FIG. 23 Global gRNA market: gRNA Type Movement Analysis
  • FIG. 24 Global gRNA market, For Research-Use, 2018 - 2030 (USD Million)
  • FIG. 25 Global gRNA market, For GMP-grade, 2018 - 2030 (USD Million)
  • FIG. 26 Global gRNA market: Application Movement Analysis
  • FIG. 27 Global gRNA market, For Genome Engineering, 2018 - 2030 (USD Million)
  • FIG. 28 Global gRNA market, For Disease Model Studies, 2018 - 2030 (USD Million)
  • FIG. 29 Global gRNA market, For Functional Genomics, 2018 - 2030 (USD Million)
  • FIG. 30 Global gRNA market, For Epigenetics, 2018 - 2030 (USD Million)
  • FIG. 31 Global gRNA market, For Others, 2018 - 2030 (USD Million)
  • FIG. 32 Global gRNA market: End-Use Movement Analysis
  • FIG. 33 Global gRNA market, For Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 34 Global gRNA market, For Academic Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 35 Global gRNA market, For CMOs & CROs, 2018 - 2030 (USD Million)
  • FIG. 36 Regional Marketplace: Key Takeaways
  • FIG. 37 Regional Outlook, 2023 & 2030
  • FIG. 38 Global gRNA market: Region Movement Analysis
  • FIG. 39 North America gRNA market, 2018 - 2030 (USD Million)
  • FIG. 40 U.S. gRNA market, 2018 - 2030 (USD Million)
  • FIG. 41 Canada gRNA market, 2018 - 2030 (USD Million)
  • FIG. 42 Europe gRNA market, 2018 - 2030 (USD Million)
  • FIG. 43 Germany gRNA market, 2018 - 2030 (USD Million)
  • FIG. 44 UK gRNA market, 2018 - 2030 (USD Million)
  • FIG. 45 France gRNA market, 2018 - 2030 (USD Million)
  • FIG. 46 Italy gRNA market, 2018 - 2030 (USD Million)
  • FIG. 47 Spain gRNA market, 2018 - 2030 (USD Million)
  • FIG. 48 Denmark gRNA market, 2018 - 2030 (USD Million)
  • FIG. 49 Sweden gRNA market, 2018 - 2030 (USD Million)
  • FIG. 50 Norway gRNA market, 2018 - 2030 (USD Million)
  • FIG. 51 Asia Pacific gRNA market, 2018 - 2030 (USD Million)
  • FIG. 52 Japan gRNA market, 2018 - 2030 (USD Million)
  • FIG. 53 China gRNA market, 2018 - 2030 (USD Million)
  • FIG. 54 India gRNA market, 2018 - 2030 (USD Million)
  • FIG. 55 Australia gRNA market, 2018 - 2030 (USD Million)
  • FIG. 56 South Korea gRNA market, 2018 - 2030 (USD Million)
  • FIG. 57 Thailand gRNA market, 2018 - 2030 (USD Million)
  • FIG. 58 Latin America gRNA market, 2018 - 2030 (USD Million)
  • FIG. 59 Brazil gRNA market, 2018 - 2030 (USD Million)
  • FIG. 60 Mexico gRNA market, 2018 - 2030 (USD Million)
  • FIG. 61 Argentina gRNA market, 2018 - 2030 (USD Million)
  • FIG. 62 Middle East And Africa gRNA market, 2018 - 2030 (USD Million)
  • FIG. 63 South Africa gRNA market, 2018 - 2030 (USD Million)
  • FIG. 64 Saudi Arabia gRNA market, 2018 - 2030 (USD Million)
  • FIG. 65 UAE gRNA market, 2018 - 2030 (USD Million)
  • FIG. 66 Kuwait gRNA market, 2018 - 2030 (USD Million)